part 3 hodgkins lymphoma

30
HODGKINS NON-HODGKINS OFTEN LOCALIZED LESION MULTIPLE NODES ORDERLY SPREAD NONCONTIGUOUS SPREAD RARE – WALDEYER/ MESENTERIC NODES COMMON UNCOMMON EXTRANODAL COMMON EXTRANODAL CLINICAL DIFFERENCES

Upload: md-specialclass

Post on 12-Nov-2014

436 views

Category:

Health & Medicine


0 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Part 3 Hodgkins  Lymphoma

HODGKINS NON-HODGKINSOFTEN LOCALIZED LESION

MULTIPLE NODES

ORDERLY SPREAD NONCONTIGUOUS SPREAD

RARE – WALDEYER/ MESENTERIC NODES

COMMON

UNCOMMON EXTRANODAL

COMMON EXTRANODAL

 CLINICAL DIFFERENCES

Page 2: Part 3 Hodgkins  Lymphoma

HODGKINS LYMPHOMA

Page 3: Part 3 Hodgkins  Lymphoma

Reed-Sternberg present◦ Derived from germinal center or post germinal

center B cells Background of Reactive Inflammatory Cells of Various types

Variable Fibrosis * LACK THE MONOMORPHIC APPEARANCE OF OTHER LYMPHOMA

CRITERIA FOR DIAGNOSIS:

Page 4: Part 3 Hodgkins  Lymphoma

Diagnostic Reed-Sternberg Cell

Page 5: Part 3 Hodgkins  Lymphoma

Account for 0.7% of new Ca in USA Arise in a Single or Chains of LN Most common Malignancy in YOUNG ADULTS ( 32y/o)

Curable in most cases May progress to NHL or Leukemia

◦spontaneously or after Tx.

FEATURES:

Page 6: Part 3 Hodgkins  Lymphoma

UnknownEBV plays a role 50% present in R-S cells (Mixed Cellularity)

High incidence Hx of IMGenetic Susceptibility

ETIOLOGY & PATHOGENESIS:

Page 7: Part 3 Hodgkins  Lymphoma

EBV (+) RS EXPRESS LATENT MEMBRANE PROTEIN-1◦PROTEIN ENCODED BY EBV◦HAS TRANSFORMING ACTIVITY◦UPREGULATES NF- Kb

EBV (-) RS cells ◦ACQUIRED MUTATION OF NEGATIVE REGULATOR OF NF-kB

ETIOLOGY & PATHOGENESIS

Page 8: Part 3 Hodgkins  Lymphoma

ACTIVATION OF NF-kB RESCUES DOOMED CELLS FROM APOPTOSIS

RS cell PRODUCE CYTOKINE ACCUM. REACTIVE CELLS SUPPORT GROWTH & SURVIVAL OF TUMOR CELLS◦IL-5, IL-6, IL-13 ,TNF

ETIOLOGY & PATHOGENESIS

Page 9: Part 3 Hodgkins  Lymphoma

PredictableSpread 1st to Contiguous Nodes◦Nodal Disease First Spleen Liver BM Extranodal

SPREAD :

Page 10: Part 3 Hodgkins  Lymphoma

Soft to hard , large Lymph Node Nodularity common in Nodular Sclerosis

Foci of necrosis + Heterogenous c/s except for LYMPHOCYTE PREDOMINANCE

Matted L.N. in Advanced cases

GROSS:

Page 11: Part 3 Hodgkins  Lymphoma

PAINLESS LYMPHADENOPATHY PAIN INVOLVED L.N. W/ ALCOHOL

◦Paraneoplastic Symptom CUTANEOUS ANERGY

◦Depressed Cellular immunity IMMUNE DYSFUNCTION

◦ UNKNOWN, PERSIST AFTER Tx. INCREASED RISK FOR 2ND CANCERS

◦AML, BREAST Ca GASTRIC Ca Limited Disease is Cured w/ Local RadioTx

CLINICAL COURSE & PROGNOSIS:

Page 12: Part 3 Hodgkins  Lymphoma

STAGE CRITERIA

I In one lymph node only

II In 2 or more LN on same side of the diaphragm

III In the Lymph nodes, Spleen, or Both AND on Both sides of the diaphragm

1 Above the renal vessels (eg. Spleen, splenic, hilar, celiac, portal nodes

2 In the lower abdomen ( periaortic, pelvic, or imguinal nodes )

IV Extranodal involvement ( eg. Bone marrow, Lung, Liver )

ANN ARBOR STAGING OF NHL & HL

A – absence of Systemic manifestationB – presence of Systemic manifestationNIGHT SWEATS, FEVER, WEIGHT LOSS

Page 13: Part 3 Hodgkins  Lymphoma

Stage I or II

Stage III or IV

Systemic s/s

Usually absent

Usually present

Type Nodular sclerosis

MC or LD

5 year disease free

90% 60-70%

CLINICAL COURSE & PROGNOSIS:

Systemic manifestation:NIGHT SWEATS, FEVER, WEIGHT LOSS

Page 14: Part 3 Hodgkins  Lymphoma

Tumor stage is most important Prognostic Variable◦ Not Histologic Type◦ R/T to current Tx protocols

Long term survivors of ChemoTx and RadioTx◦ Increased risk fro secondary Ca◦ Breast Ca common in:

Females Tx w/ RadioTx to chest during adolescence◦ AML/ Myelodysplastic syndrome common

ChemoTx

CLINICAL COURSE & PROGNOSIS:

Page 15: Part 3 Hodgkins  Lymphoma

NODULAR SCLEROSIS

Page 16: Part 3 Hodgkins  Lymphoma

MOST COMMON 65-70%MALE = FEMALESADOLESCENT & YOUNG ADULTS

EXCELLENT PROGNOSIS

Features:

Page 17: Part 3 Hodgkins  Lymphoma

Stage 1 or 2 LOWER CERVICAL , SUPRACLAVICULAR & MEDIASTINAL L.N.

RARELY ASSOC. EBV

Clinical Maniifestation

Page 18: Part 3 Hodgkins  Lymphoma

LACUNAR TYPE AbundantCOLLAGEN BAND NODULARPOLYMORPHOUS BACKGROUND

DXTIC RS CELLS LESS FREQUENT

Morphology

Page 19: Part 3 Hodgkins  Lymphoma

Morphology

Page 20: Part 3 Hodgkins  Lymphoma

Lacunar Type of RS cell

LACUNAR RS

Page 21: Part 3 Hodgkins  Lymphoma

Mixed Cellularity

Page 22: Part 3 Hodgkins  Lymphoma

20-25 % MALES > FEMALES STRONGLY ASSOC. W/ EBV OLDER & YOUNG ADULTS ( BIPHASIC ) > 50% PRESENT AS STAGE 3-4

accompanied by SYSTEMIC SYMPTOMS

Prognosis Very Good

MIXED CELLULARITY

Page 23: Part 3 Hodgkins  Lymphoma

Microscopic

FREQUENTLY SEEMONONUCLEAR & DXTIC RS CELLS

DXTIC RS CELLSAre numerousMONONUCLEAR

Page 24: Part 3 Hodgkins  Lymphoma

LYMPHOCYTE RICH TYPE

Page 25: Part 3 Hodgkins  Lymphoma

 UNCOMMON M>F OLDER ADULTS FREQUENT MONONUCLEAR AND DXTIC R-S CELLS◦REACTIVE T LYMPHOS PREDOMINATES

40% EBV ASSOC. PROGNOSIS EXCELLENT

LYMPHOCYTE RICH TYPE

Page 26: Part 3 Hodgkins  Lymphoma

LYMPHOCYTE - PREDOMINANCE

Page 27: Part 3 Hodgkins  Lymphoma

5% OF CASES , UNCOMMONMALES > FEMALES ( < 35 y/o )

◦Asymptomatic YOUNG MALES WITH CERVICAL OR AXILLARY LYMPHADENOPATHY

◦MEDIASTINAL INVOLVEMENT IS RARENOT ASSOC. W/ EBVPROGNOSIS EXCELLENT

LYMPHOCYTE - PREDOMINANCE

Page 28: Part 3 Hodgkins  Lymphoma

NODULAR PATTERN DUE TO EXPANDED B-CELL FOLLICLES◦POPULATED BY L&H CELLS AND

REACTIVE B-CELL◦DXTIC RS DIFFICULT TO FIND

3-5% PROGRESS DIFFUSE LARGE CELL  

LYMPHOCYTE - PREDOMINANCE:

Page 29: Part 3 Hodgkins  Lymphoma

Microscopic – Difficult to find diagnostic RS cells

POPCORN RS CELLSL & H variants

NUMEROUS MATURELYMPHOCYTES

Page 30: Part 3 Hodgkins  Lymphoma

<5 % LEAST COMMON OFTEN ASSOC. EBV COMMON

* OLDER PTS.* HIV * NON-INDUSTRIALIZED COUNTRIES

SYSTEMIC SYMPTOMS PRESENT AS ADVANCED STAGE PROGNOSIS LESS FAVORABLE

LYMPHOCYTE DEPLETION TYPE :